Compounding Education
    Verification Guide

    How to Verify Your Compounding Pharmacy Is Legitimate

    A practical, step-by-step guide to confirming your compounding pharmacy is properly licensed, registered, and safe.

    Last updated: April 3, 202613 min read

    Before trusting any compounding pharmacy with your GLP-1 medication, take a few minutes to verify their credentials. This guide walks you through exactly how to do it using free, publicly available databases.

    Step 1: Check FDA Registration (503B Facilities)

    FDA Outsourcing Facility Database

    1. 1. Visit FDA.gov and navigate to the Registered Outsourcing Facilities page
    2. 2. Search by pharmacy name, city, or state
    3. 3. Confirm the facility appears on the list with active registration
    4. 4. Note any FDA warning letters or enforcement actions linked to the facility

    If a pharmacy claims to be a 503B outsourcing facility but does not appear in the FDA database, do not use them.

    Important: 503A pharmacies (traditional compounding pharmacies) are not required to register with the FDA. They are regulated by state pharmacy boards instead. If a pharmacy is a 503A, skip to Step 2.

    Step 2: Verify State Pharmacy Board License

    State License Verification

    1. 1. Identify the state where the pharmacy is physically located
    2. 2. Visit that state's Board of Pharmacy website
    3. 3. Use the license lookup or verification tool
    4. 4. Search by pharmacy name or license number
    5. 5. Confirm the license is active and in good standing
    6. 6. Check for any disciplinary actions, fines, or restrictions

    Every compounding pharmacy -- both 503A and 503B -- must hold an active state pharmacy license. If they compound and ship to patients in other states, they typically need non-resident pharmacy licenses in those states as well.

    Step 3: Check for PCAB or Other Accreditations

    The Pharmacy Compounding Accreditation Board (PCAB), administered by the Accreditation Commission for Health Care (ACHC), offers a voluntary accreditation program for compounding pharmacies. While not required, PCAB accreditation demonstrates a pharmacy's commitment to quality:

    • Comprehensive on-site inspection of facilities and processes
    • Review of quality assurance protocols
    • Staff competency evaluation
    • Ongoing compliance monitoring

    You can verify PCAB accreditation at the ACHC website by searching for the pharmacy name.

    Step 4: Request Documentation

    A legitimate compounding pharmacy should be willing and able to provide the following documentation upon request:

    Documentation Checklist

    • Certificate of Analysis (COA) for API: From their semaglutide/tirzepatide supplier showing purity, identity, and quality
    • Finished product potency testing: Third-party lab results confirming the labeled concentration is accurate
    • Sterility testing results: Confirming the injectable product is free of microbial contamination
    • Endotoxin testing results: Confirming acceptable endotoxin levels for injectable use
    • State pharmacy license number: Verifiable through the state board
    • FDA registration number (503B): If they claim 503B status

    Step 5: Contact the Pharmacy Directly

    Questions to Ask

    • • Are you a 503A or 503B compounding pharmacy?
    • • Can I speak with the pharmacist-in-charge?
    • • Where do you source your semaglutide/tirzepatide API?
    • • Do you use semaglutide base or semaglutide sodium?
    • • What third-party testing do you perform on finished products?
    • • Can you provide your most recent potency and sterility test results?
    • • What is the beyond-use dating on your compounded semaglutide?
    • • How do you ship medications to maintain cold chain?

    A reputable pharmacy will welcome these questions. Evasiveness or refusal to answer should be treated as a red flag.

    Quick Verification Checklist

    Complete Verification Checklist

    Verification StepWhere to CheckTime Required
    FDA 503B registrationFDA.gov outsourcing facility list2 minutes
    State pharmacy licenseState Board of Pharmacy website3 minutes
    PCAB accreditationACHC website2 minutes
    Physical address verificationGoogle Maps / online search2 minutes
    Request COA and test resultsContact pharmacy directly5-10 minutes
    Check for FDA warning lettersFDA.gov warning letters database3 minutes

    Conclusion

    Verifying your compounding pharmacy takes about 15-20 minutes and provides significant peace of mind. In a market where demand for GLP-1 medications far outstrips supply, this small investment of time can protect you from unsafe products. Legitimate pharmacies welcome scrutiny because it distinguishes them from bad actors.

    Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any medication.

    Pre-Verified Pharmacy Partners

    We have done the verification for you. Our pharmacy partners are FDA-registered, state-licensed, and third-party tested.

    Get Started Today

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    What does the current clinical evidence support for GLP-1-based weight management?

    GLP-1 receptor agonists (semaglutide, tirzepatide) have Phase 3 RCT evidence for chronic weight management in adults with BMI ≥30 or BMI ≥27 with a weight-related comorbidity. Trimi offers compounded preparations of the same active ingredients at $99/month (semaglutide) and $125/month (tirzepatide) on the annual plan, prepared per individual prescription by 503A community sterile compounding pharmacies and reviewed by a US-licensed clinician through Beluga Health's 50-state physician network. Compounded preparations are not themselves FDA-approved as drugs; the active ingredients are FDA-approved in the corresponding brand finished products. Eligibility is determined by a licensed clinician.

    Phase 3 RCT evidence base: STEP 1 (NEJM 2021), SURMOUNT-1 (NEJM 2022), SELECT (NEJM 2023), FLOW (NEJM 2024)
    Trimi pricing: $99/month semaglutide / $125/month tirzepatide on annual plan
    Clinical review: Dr. Asad Niazi, MD MPH via Beluga Health 50-state network

    Key Takeaways

    • Compounded semaglutide and compounded tirzepatide are prepared per individual prescription by 503A community sterile compounding pharmacies (VialsRx — Texas State Board pharmacy license #35264 — and GreenwichRx). The active ingredients (semaglutide, tirzepatide) are FDA-approved in the corresponding brand finished products (Wegovy / Ozempic and Zepbound / Mounjaro respectively). Compounded preparations are not themselves FDA-approved as drugs.
    • Eligibility for GLP-1 treatment is determined by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal/family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Most are mild-to-moderate and concentrated during dose escalation. Severe gastrointestinal symptoms causing dehydration can increase acute kidney injury risk and should be reported to the prescribing clinician.
    • Trimi's clinical review is coordinated by Dr. Asad Niazi, MD MPH through Beluga Health's 50-state physician network. Trimi pricing: $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan; flat across all prescribed doses within whichever plan, with no enrollment / consultation / shipping fees.
    • This is general information based on the cited sources, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: December 11, 2025

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    I'm on my 4th week. No side effects. 5 lb loss which seems slow to me. Food noise is much better. We shall see!

    Outcome: 5 lbs lost in 4 weeks; no side effects; food noise reduced

    Lynn SchweitzerFacebook
    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    Robyn Lynn CurtisFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Garvey WT, Mechanick JI, Brett EM, et al. (2024). American Association of Clinical Endocrinology / American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice.Read StudyDOI: 10.4158/EP161365.GL
    2. American Heart Association (2021). Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation.Read StudyDOI: 10.1161/CIR.0000000000000973
    3. Apovian CM, Aronne LJ, Bessesen DH, et al. (2015). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism.Read StudyDOI: 10.1210/jc.2014-3415

    Was this article helpful?

    Keep Reading

    Step-by-step retatrutide injection: 6-day half-life, once-weekly dosing, site rotation, and how to time shots for fewer side effects and better weight loss results.

    Buy compounded semaglutide online in Texas for $99/month. Learn about Texas telehealth laws, compounding pharmacy access, and how to start affordable GLP-1 weight loss treatment.

    What to expect in your first month on retatrutide: realistic weight loss expectations, side effects, appetite changes, and tips for maximizing early results during the dose titration phase.

    Complete guide to semaglutide 1.7mg dosing. Learn about expected weight loss results, side effects at this higher dose, and how to decide between staying at 1.7mg or advancing to 2.4mg.

    Start your GLP-1 journey — from $99/mo

    Get Started